The following pages link to Clinical Trials (Q5693362):
Displayed 22 items.
- An Empirical Bayes Method for Multivariate Meta-analysis with an Application in Clinical Trials (Q79700) (← links)
- Global testing under sparse alternatives: ANOVA, multiple comparisons and the higher criticism (Q661170) (← links)
- Interval estimation of odds ratio in a stratified randomized clinical trial with noncompliance (Q961707) (← links)
- A class of mean residual life regression models with censored survival data (Q989269) (← links)
- Randomized group up and down experiments (Q1039833) (← links)
- Choice as an alternative to control in observational studies. (With comments and a rejoinder). (Q1431170) (← links)
- Statistical analysis of survival and reliability data with multiple crossings of survival functions (Q1771044) (← links)
- Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design (Q2000854) (← links)
- Building an identifiable latent class model with covariate effects on underlying and measured variables (Q2259976) (← links)
- Estimating Incidence Rate on Current Status Data with Application to a Phase IV Cancer Trial (Q2865261) (← links)
- A New Semiparametric Estimation Method for Accelerated Hazard Model (Q2893393) (← links)
- Accelerated Hazards Regression Model and Its Adequacy for Censored Survival Data (Q3078830) (← links)
- Designs for Single- or Multiple-Agent Phase I Trials (Q3445286) (← links)
- GROUP SEQUENTIAL TESTS WITH OUTCOME-DEPENDENT TREATMENT ASSIGNMENT (Q4331107) (← links)
- Chain Graph Models and their Causal Interpretations (Q4665889) (← links)
- Sample Size Re-Estimation Based on Two-Stage Analysis of Variance: Interim Analysis of Clinical Trials (Q4904676) (← links)
- Semiparametric Bayesian Survival Analysis using Models with Log‐linear Median (Q4911939) (← links)
- Confidence interval for the difference between two median survival times with semiparametric transformation models (Q5084010) (← links)
- Simulation of clinical trials: a review with emphasis on the design issues (Q5148592) (← links)
- Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials (Q5424143) (← links)
- Semiparametric Estimation of Proportional Mean Residual Life Model in Presence of Censoring (Q5715366) (← links)
- Stratified Analysis in Randomized Trials with Noncompliance (Q5717164) (← links)